Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

NCT01290601 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

FED

Sponsor class

Stopped Failure to meet pre-specified endpoint for the day 28 cure rate

Conditions

Malaria
Plasmodium Vivax

Interventions

DRUG: Tafenoquine
DRUG: Chloroquine + Primaquine
DRUG: tafenoquine
DRUG: Chloroquine + Primaquine

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]